Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Journal of Crohn'S & Colitis
|
September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID
Pauline Wils, Romain Altwegg, Anthony Buisson, et al.
United European Gastroenterology Journal
|
August 19, 2025
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey
Ana Catarina Bravo, Sara Godt Christensen, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
Mathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study
Mathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Journal of Crohn'S & Colitis
|
March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID
Aurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis
|
November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease
Sara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis
Sailish Honap, Joelle St-Pierre, Michael Colwill, et al.
United European Gastroenterology Journal
|
March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID
Louis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine
David Laharie, Arnaud Bourreille, Julien Branche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 29, 2026
Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic era
Matthieu Allez, Michiel T J Bak, Sofia Brand, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Journal of Crohn'S & Colitis
|
September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID
Pauline Wils, Romain Altwegg, Anthony Buisson, et al.
United European Gastroenterology Journal
|
August 19, 2025
Patient and First-Degree Relatives Perceptions About Prediction and Prevention of Inflammatory Bowel Disease-A Multinational Survey
Ana Catarina Bravo, Sara Godt Christensen, Mette Julsgaard, et al.
Alimentary Pharmacology & Therapeutics
|
May 22, 2025
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
Mathilde Osty, Romain Altwegg, Mélanie Serrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 10, 2024
Long-term Outcome of Risankizumab in Crohn's Disease: a Real-world GETAID Study
Mathurin Fumery, Benedicte Caron, Xavier Hébuterne, et al.
Journal of Crohn'S & Colitis
|
March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID
Aurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.
Journal of Crohn'S & Colitis
|
November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease
Sara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 28, 2025
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis
Sailish Honap, Joelle St-Pierre, Michael Colwill, et al.
United European Gastroenterology Journal
|
March 25, 2026
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID
Louis Calméjane, Catherine Reenaers, Claire Gay, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 11, 2020
Evolution of Endoscopic Lesions in Steroid-Refractory Acute Severe Ulcerative Colitis Responding to Infliximab or Cyclosporine
David Laharie, Arnaud Bourreille, Julien Branche, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 29, 2026
Development and external validation of a predictive model for postoperative recurrence of Crohn's disease in the biologic era
Matthieu Allez, Michiel T J Bak, Sofia Brand, et al.
Page
of 17